British Columbia Investment Management Corp Novo Cure LTD Transaction History

British Columbia Investment Management Corp

$16 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $10,757 - $22,030	267 Added 3.22%	8,570 $355,000
Q4 2022 Feb 10, 2023	SELL	$63.98 - $85.37 $58,029 - $77,430	-907 Reduced 9.85%	8,303 $609,000
Q3 2022 Nov 10, 2022	SELL	$67.99 - $89.57 $108,240 - $142,595	-1,592 Reduced 14.74%	9,210 $700,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $205,061 - $325,707	-3,623 Reduced 25.12%	10,802 $751,000
Q1 2022 May 12, 2022	SELL	$60.15 - $84.52 $114,946 - $161,517	-1,911 Reduced 11.7%	14,425 $1.2 Million
Q4 2021 Feb 11, 2022	SELL	$75.08 - $121.99 $67,196 - $109,181	-895 Reduced 5.19%	16,336 $1.23 Million
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $23,698 - $39,688	204 Added 1.2%	17,231 $2 Million
Q2 2021 Aug 09, 2021	BUY	$130.4 - $225.58 $373,596 - $646,286	2,865 Added 20.23%	17,027 $3.78 Million
Q1 2021 Apr 30, 2021	SELL	$124.11 - $190.17 $43,810 - $67,130	-353 Reduced 2.43%	14,162 $1.87 Million
Q4 2020 Feb 02, 2021	BUY	$112.16 - $174.14 $1.63 Million - $2.53 Million	14,515 New	14,515 $2.51 Million

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.

Account